State Street’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6M Buy
972,088
+257,066
+36% +$4.11M ﹤0.01% 2324
2025
Q1
$13.9M Buy
715,022
+123,930
+21% +$2.41M ﹤0.01% 2326
2024
Q4
$13M Buy
591,092
+147,392
+33% +$3.25M ﹤0.01% 2468
2024
Q3
$7.47M Buy
443,700
+30,052
+7% +$506K ﹤0.01% 2768
2024
Q2
$4.94M Buy
413,648
+104,754
+34% +$1.25M ﹤0.01% 2936
2024
Q1
$3.42M Buy
308,894
+19,070
+7% +$211K ﹤0.01% 3087
2023
Q4
$2.51M Buy
289,824
+62,136
+27% +$538K ﹤0.01% 3241
2023
Q3
$1.74M Buy
227,688
+7,642
+3% +$58.5K ﹤0.01% 3383
2023
Q2
$1.58M Sell
220,046
-288
-0.1% -$2.07K ﹤0.01% 3485
2023
Q1
$1.34M Buy
220,334
+41,904
+23% +$255K ﹤0.01% 3447
2022
Q4
$778K Sell
178,430
-64,143
-26% -$280K ﹤0.01% 3622
2022
Q3
$951K Buy
242,573
+5,752
+2% +$22.6K ﹤0.01% 3606
2022
Q2
$1.21M Buy
236,821
+81,381
+52% +$415K ﹤0.01% 3596
2022
Q1
$995K Buy
155,440
+26,240
+20% +$168K ﹤0.01% 3817
2021
Q4
$1.04M Buy
129,200
+112,991
+697% +$906K ﹤0.01% 3808
2021
Q3
$150K Buy
+16,209
New +$150K ﹤0.01% 4452